Teethgrinder – Lifestyle
Author:
Kuros Biosciences AG
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
May 7, 2026
Annual General Meeting of Kuros Biosciences approves all resolutions
April 15, 2026
Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026
April 14, 2026
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
March 10, 2026